Literature DB >> 30704273

Intracardiac Delineation of Septal Conduction in Left Bundle-Branch Block Patterns.

Gaurav A Upadhyay1, Tharian Cherian1, Dalise Y Shatz1, Andrew D Beaser1, Zaid Aziz1, Cevher Ozcan1, Michael T Broman1, Hemal M Nayak1, Roderick Tung1.   

Abstract

BACKGROUND: Septal activation in patients with left bundle-branch block (LBBB) patterns has not been described previously. We performed detailed intracardiac mapping of left septal conduction to assess for the presence and level of complete conduction block (CCB) in the His-Purkinje system. Response to His bundle pacing was assessed in patients with and without CCB in the left bundle.
METHODS: Left septal mapping was performed with a linear multielectrode catheter in consecutive patients with LBBB pattern referred for device implantation (n=38) or substrate mapping (n=47). QRS width, His duration, His-ventricular (HV) intervals, and septal conduction patterns were analyzed. The site of CCB was localized to the level of the left-sided His fibers (left intrahisian) or left bundle branch. Patients with ventricular activation preceded by Purkinje potentials were categorized as having intact Purkinje activation.
RESULTS: A total of 88 left septal conduction recordings were analyzed in 85 patients: 72 LBBB block pattern and 16 controls (narrow QRS, n=11; right bundle-branch block, n=5). Among patients with LBB block pattern, CCB within the proximal left conduction system was observed in 64% (n=46) and intact Purkinje activation in the remaining 36% (n=26). Intact Purkinje activation was observed in all controls. The site of block in patients with CCB was at the level of the left His bundle in 72% and in the proximal left bundle branch in 28%. His bundle pacing corrected wide QRS in 54% of all patients with LBBB pattern and 85% of those with CCB (94% left intrahisian, 62% proximal left bundle-branch). No patients with intact Purkinje activation demonstrated correction of QRS with His bundle pacing. CCB showed better predictive value (positive predictive value 85%, negative predictive value 100%, sensitivity 100%) than surface ECG criteria for correction with His bundle pacing.
CONCLUSIONS: Heterogeneous septal conduction was observed in patients with surface LBBB pattern, ranging from no discrete block to CCB. When block was present, we observed pathology localized within the left-sided His fibers (left intrahisian block), which was most amenable to corrective His bundle pacing by recruitment of latent Purkinje fibers. ECG criteria for LBBB incompletely predicted CCB, and intracardiac data might be useful in refining patient selection for resynchronization therapy.

Entities:  

Keywords:  His bundle; left bundle; pacing; resynchronization

Mesh:

Year:  2019        PMID: 30704273     DOI: 10.1161/CIRCULATIONAHA.118.038648

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  Feasibility and safety of both His bundle pacing and left bundle branch area pacing in atrial fibrillation patients: intermediate term follow-up.

Authors:  Yang Ye; Kai Zhang; Ying Yang; Dongmei Jiang; Yiwen Pan; Xia Sheng; Bei Wang; Chan Yu; Zuwen Zhang; Jiefang Zhang; Li Wang; Jiangfen Jiang; Yaxun Sun; Qiang Liu; Yunxian Cheng; Bo Gao; Min Wang; Hong He; Chenyang Jiang; Guosheng Fu
Journal:  J Interv Card Electrophysiol       Date:  2021-03-15       Impact factor: 1.900

2.  Cerclage parahisian septal pacing through the septal perforator branch of the great cardiac vein: Bedside-to-bench development of a novel technique and lead.

Authors:  Min Soo Cho; Min Ku Chon; Jin Hee Choi; Ki Won Hwang; Jeong-Wook Seo; Robert J Lederman; June Hong Kim; Gi-Byoung Nam
Journal:  Heart Rhythm       Date:  2019-08-30       Impact factor: 6.343

Review 3.  Physiologic Pacing Targeting the His Bundle and Left Bundle Branch: a Review of the Literature.

Authors:  Seth D Scheetz; Gaurav A Upadhyay
Journal:  Curr Cardiol Rep       Date:  2022-06-09       Impact factor: 3.955

4.  Leadless Left Bundle Branch Area Pacing in Cardiac Resynchronisation Therapy: Advances, Challenges and Future Directions.

Authors:  Nadeev Wijesuriya; Mark K Elliott; Vishal Mehta; Baldeep S Sidhu; Marina Strocchi; Jonathan M Behar; Steven Niederer; Christopher A Rinaldi
Journal:  Front Physiol       Date:  2022-06-06       Impact factor: 4.755

Review 5.  Electrical management of heart failure: from pathophysiology to treatment.

Authors:  Frits W Prinzen; Angelo Auricchio; Wilfried Mullens; Cecilia Linde; Jose F Huizar
Journal:  Eur Heart J       Date:  2022-05-21       Impact factor: 35.855

6.  Left bundle branch area pacing delivery of cardiac resynchronization therapy and comparison with biventricular pacing.

Authors:  Xiaofei Li; Chunguang Qiu; Ruiqin Xie; Wentao Ma; Zhao Wang; Hui Li; Hao Wang; Wei Hua; Shu Zhang; Yan Yao; Xiaohan Fan
Journal:  ESC Heart Fail       Date:  2020-05-13

7.  Left ventricular paced activation in cardiac resynchronization therapy patients with left bundle branch block and relationship to its electrical substrate.

Authors:  Brian J Wisnoskey; Niraj Varma
Journal:  Heart Rhythm O2       Date:  2020-05-11

8.  Sex differences in left ventricular electrical dyssynchrony and outcomes with cardiac resynchronization therapy.

Authors:  Daniel J Friedman; Kasper Emerek; Peter L Sørensen; Emily P Zeitler; Sarah A Goldstein; Sana M Al-Khatib; Peter Søgaard; Claus Graff; Brett D Atwater
Journal:  Heart Rhythm O2       Date:  2020-08-04

9.  Effect of Nonselective His Bundle Pacing on Delayed Myocardial Activation in Left-axis Deviation and Left Bundle Branch Block.

Authors:  Rehan Mahmud; Shakeel Jamal; Stacey Kukla; Brenda Harris
Journal:  J Innov Card Rhythm Manag       Date:  2021-07-15

10.  Progression of incomplete toward complete left bundle branch block: A clinical and electrocardiographic analysis.

Authors:  Ellie Senesael; Simon Calle; Victor Kamoen; Roland Stroobandt; Marc De Buyzere; Frank Timmermans; Jan De Pooter
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-12-11       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.